دورية أكاديمية
أعرض في EDS

Adoption of Wearable Insulin Biosensors for Diabetes Management: A Cross-Sectional Study.

التفاصيل البيبلوغرافية
العنوان: Adoption of Wearable Insulin Biosensors for Diabetes Management: A Cross-Sectional Study.
المؤلفون: Alanzi TM; Department of Health Information Management and Technology, College of Public Health, Imam Abdulrahman Bin Faisal University, Dammam, SAU., Alzahrani W; Department of Clinical Nutrition, College of Applied Medical Sciences, King Abdulaziz University, Jeddah, SAU., Almoraikhi M; ‏College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, SAU., Algannas A; ‏‏College of Medicine, Al Baha University, Al Baha, SAU., Alghamdi M; Department of Pharmaceutical Services, Dhahran Long Term Care Hospital, Dhahran, SAU., Alzahrani L; College of Medicine, ‏King Abdulaziz University, Jeddah, SAU., Abutaleb R; College of Pharmacy, Jazan University, Jazan, SAU., Ba Dughaish R; College of Medicine, Alfaisal University, Riyadh, SAU., Alotibi N; College of Pharmacy, Shaqra University, Shaqra, SAU., Alkhalifah S; College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, SAU., Alshehri M; ‏College of Medicine, Princess Nourah Bint Abdul Rahman University, Riyadh, SAU., Alzahrani H; College of Pharmacy, Taif University, Taif, SAU., Almahdi R; ‏College of Medicine, Al Baha University, Al Baha, SAU., Alanzi N; Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Jouf University, Jouf, SAU., Farhah N; Department of Health Informatics, College of Health Sciences, Saudi Electronic University, Riyadh, SAU.
المصدر: Cureus [Cureus] 2023 Dec 19; Vol. 15 (12), pp. e50782. Date of Electronic Publication: 2023 Dec 19 (Print Publication: 2023).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Palo Alto, CA : Cureus, Inc.
مستخلص: Background: Wearable insulin biosensors represent a novel approach that combines the benefits of real-time glucose monitoring and automated insulin delivery, potentially revolutionizing how individuals with diabetes manage their condition.
Study Purpose: To analyze the behavioral intentions of wearable insulin biosensors among diabetes patients, the factors that drive or hinder their usage, and the implications for diabetes management and healthcare outcomes.
Methods: A cross-sectional survey design was adopted in this study. The validated questionnaire included 10 factors (Performance expectancy, effort expectancy, social influence, facilitating conditions, behavioral intention, trust, perceived privacy risk, and personal innovativeness) affecting the acceptance of wearable insulin sensors. A total of 248 diabetic patients who had used wearable sensors participated in the study.
Results: Performance expectancy was rated the highest (Mean = 3.84 out of 5), followed by effort expectancy (Mean = 3.78 out of 5), and trust (Mean = 3.53 out of 5). Statistically significant differences (p < 0.05) were observed with respect to socio-demographic variables including age and gender on various influencing factors and adoption intentions. PE, EE, and trust were positively associated with adoption intentions.
Conclusion: While wearable insulin sensors are positively perceived with respect to diabetes management, issues like privacy and security may affect their adoption.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2023, Alanzi et al.)
References: World J Clin Cases. 2021 Oct 16;9(29):8666-8670. (PMID: 34734045)
N Engl J Med. 2022 Oct 20;387(16):1477-1487. (PMID: 36198143)
Am J Lifestyle Med. 2019 Dec 12;14(2):130-132. (PMID: 32231476)
Diabetes Ther. 2019 Apr;10(2):341-366. (PMID: 30815830)
Diabet Med. 2020 Mar;37(3):455-463. (PMID: 31797455)
J Clin Med. 2022 Nov 28;11(23):. (PMID: 36498594)
Nat Rev Endocrinol. 2023 Aug;19(8):487-495. (PMID: 37217746)
J Med Internet Res. 2019 Aug 13;21(8):e15023. (PMID: 31411146)
Am J Med Sci. 2019 Nov;358(5):332-339. (PMID: 31402042)
J Gen Intern Med. 2022 Mar;37(4):870-877. (PMID: 34993873)
Front Public Health. 2022 Jan 03;9:773293. (PMID: 35047473)
Nanomaterials (Basel). 2022 Jan 10;12(2):. (PMID: 35055239)
Lancet Diabetes Endocrinol. 2022 Jan;10(1):75-84. (PMID: 34793722)
Diabetes Care. 2022 Aug 1;45(8):1724-1734. (PMID: 35696191)
JMIR Form Res. 2023 Apr 6;7:e42087. (PMID: 37023419)
Front Bioeng Biotechnol. 2021 Aug 19;9:733810. (PMID: 34490230)
Front Psychol. 2022 Oct 18;13:993935. (PMID: 36329748)
Nurs Res. 2021 Nov-Dec 01;70(6):487-497. (PMID: 34292228)
Interact J Med Res. 2020 Sep 18;9(3):e19776. (PMID: 32945778)
Cureus. 2022 Jul 20;14(7):e27066. (PMID: 36000101)
Nat Biomed Eng. 2022 Nov;6(11):1225-1235. (PMID: 35970928)
Lancet Diabetes Endocrinol. 2023 Jan;11(1):42-57. (PMID: 36493795)
J Diabetes Sci Technol. 2018 May;12(3):587-591. (PMID: 29542348)
Sensors (Basel). 2022 Jan 14;22(2):. (PMID: 35062598)
Biosens Bioelectron. 2022 Aug 1;209:114251. (PMID: 35405503)
Saudi J Med Med Sci. 2023 Jan-Mar;11(1):1-10. (PMID: 36909010)
JMIR Diabetes. 2022 Jan 27;7(1):e31451. (PMID: 35084357)
Diabetes Care. 2020 Sep;43(9):2017-2024. (PMID: 32641374)
فهرسة مساهمة: Keywords: adoption; artificial intelligence; biosensors; diabetes; insulin; monitoring; trust
تواريخ الأحداث: Date Created: 20240119 Latest Revision: 20240121
رمز التحديث: 20240121
مُعرف محوري في PubMed: PMC10795719
DOI: 10.7759/cureus.50782
PMID: 38239544
قاعدة البيانات: MEDLINE
الوصف
تدمد:2168-8184
DOI:10.7759/cureus.50782